Description
Join Sharsheret's Israel Office in partnership with the Israel Cancer Research Foundation (ICRF) for exciting breast cancer research updates with Dr. Albert Grinshpun, MD, MSc.
Location
Zoom Link Sent Upon Registration
Date & Time
Monday, May 4 at 2000 Israel / 1pm est / 10am pst
Join Sharsheret's Israel Office in partnership with the Israel Cancer Research Foundation (ICRF) for exciting breast cancer research updates with Dr. Albert Grinshpun, MD, MSc. Dr. Grinshpun's ICRF-funded research is changing the way doctors can monitor cancer treatments, using a simple blood test or "liquid biopsy." Moderated by Liora Tannenbaum, Sharsheret's Israel Region Director, with special remarks from Dr. Arnold Baskies, Chair of ICRF, this webinar will provide updates on this research and other advances in breast cancer research coming out of Israel.
Please contact Bonnie Beckoff with any questions or for more information.
Expert Bio:
Dr. Albert Grinshpun completed his M.D. at the Hebrew University in Jerusalem, Israel in 2010. During his M.D. he also completed M.Sc. in gene therapy. Then, he went on and completed his service in the Israel Defense Forces, followed by a residency in Medical Oncology at the Sharett Institute of Oncology of the Hadassah-Hebrew University Medical Center, Jerusalem.
During training, Albert accomplished a basic research fellowship at the Weizmann Institute where he investigated tumor microbiome. Notably, while being a resident, Albert won several highly prestigious competitive grants including the Ministry of Science Personalized Medicine grant, Physician-Scientist award from the Israel Science Foundation (ISF), and the Conquer Cancer (ASCO)-Israel Cancer Research Fund Career Development Award.
After completion of his training, Dr. Grinshpun joined the international Goldfarb Advanced Fellowship program in Medical Oncology at Dana-Farber/Harvard Cancer Center in Boston. Albert studied mechanisms of endocrine resistance in metastatic hormone receptor-positive breast cancer and ctDNA studies, mentored by Drs. Lin and Jeselsohn of Dana-Farber. In parallel, Albert was involved in translational research, clinical trial design and multidisciplinary patient care.
Dr. Grinshpun has published more than 40 peer reviewed original articles. Among these publications are manuscripts published in Annals of Oncology and JAMA Oncology.
In August 2023 Albert returned to Israel and currently he's leading the Breast Oncology Service at Shaare Zedek Medical Center, Jerusalem. In addition, Albert is leading a research team focused on Women's cancers, affiliated to the Hebrew University of Jerusalem.
During training, Albert accomplished a basic research fellowship at the Weizmann Institute where he investigated tumor microbiome. Notably, while being a resident, Albert won several highly prestigious competitive grants including the Ministry of Science Personalized Medicine grant, Physician-Scientist award from the Israel Science Foundation (ISF), and the Conquer Cancer (ASCO)-Israel Cancer Research Fund Career Development Award.
After completion of his training, Dr. Grinshpun joined the international Goldfarb Advanced Fellowship program in Medical Oncology at Dana-Farber/Harvard Cancer Center in Boston. Albert studied mechanisms of endocrine resistance in metastatic hormone receptor-positive breast cancer and ctDNA studies, mentored by Drs. Lin and Jeselsohn of Dana-Farber. In parallel, Albert was involved in translational research, clinical trial design and multidisciplinary patient care.
Dr. Grinshpun has published more than 40 peer reviewed original articles. Among these publications are manuscripts published in Annals of Oncology and JAMA Oncology.
In August 2023 Albert returned to Israel and currently he's leading the Breast Oncology Service at Shaare Zedek Medical Center, Jerusalem. In addition, Albert is leading a research team focused on Women's cancers, affiliated to the Hebrew University of Jerusalem.
*Disclaimer: By joining this program I understand and acknowledge that Sharsheret is not providing medical advice. Additionally, I release and waive Sharsheret from any liability in the event of any accident or injury I may incur either during the course of this webinar or in performing any of the activities discussed during the same.
All views shared on the webinar are of the speakers and are independent of the program sponsors. To the best knowledge of Sharsheret, no relationship exists between the sponsors and the speakers, and no payment has or will be made by the sponsor to the speakers in connection with this webinar.
